| Comparative study on DOTA-derivatized bombesin analog labeled with 90Y and 177Lu: in vitro and in vivo evaluation E Koumarianou, R Mikołajczak, D Pawlak, X Zikos, P Bouziotis, ... Nuclear medicine and biology 36 (6), 591-603, 2009 | 42 | 2009 |
| Metal nanozymes: New horizons in cellular homeostasis regulation H Lewandowska, K Wojciuk, U Karczmarczyk Applied Sciences 11 (19), 9019, 2021 | 19 | 2021 |
| Standardization of Procedures for the Preparation of 177Lu-and 90Y-labeled DOTA-Rituximab Based on the Freeze-dried Kit Formulation W Wojdowska, U Karczmarczyk, M Maurin, P Garnuszek, R Mikolajczak Current Radiopharmaceuticals 8 (1), 62-68, 2015 | 18 | 2015 |
| Investigation of 99mTc-labelling of recombinant human interleukin-2 via hydrazinonicotinamide U Karczmarczyk, P Garnuszek, M Maurin, V Di Gialleonardo, F Galli, ... Nuclear medicine and biology 37 (7), 795-803, 2010 | 18 | 2010 |
| Oxidation of methionine—is it limiting the diagnostic properties of 99mTc-labeled Exendin-4, a Glucagon-Like Peptide-1 receptor agonist? B Janota, U Karczmarczyk, E Laszuk, P Garnuszek, R Mikołajczak Nuclear Medicine Review 19 (2), 104-110, 2016 | 15 | 2016 |
| Imaging of inflamed carotid artery atherosclerotic plaques with the use of 99mTc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients M Opalinska, T Stompor, D Pach, R Mikolajczak, D Fedak, M Krzanowski, ... European journal of nuclear medicine and molecular imaging 39, 673-682, 2012 | 14 | 2012 |
| Identification of Inflamed Atherosclerotic Plaque using 123I-Labeled Interleukin-2 Scintigraphy in High-Risk Peritoneal Dialysis Patients: A Pilot Study A Hubalewska–Dydejczyk, T Stompór, M Kalembkiewicz, M Krzanowski, ... Peritoneal dialysis international 29 (5), 568-574, 2009 | 13 | 2009 |
| 99m Tc human IgG radiolabelled by HYNIC. Biodistribution and scintigraphy of experimentally induced inflammatory lesions in animal model U Karczmarczyk, A Markiewicz, R Mikołajczak, E Lisiak, M Bilski, ... Nuclear Medicine Review 7 (2), 107-112, 2004 | 13 | 2004 |
| Design and Evaluation of 223Ra-Labeled and Anti-PSMA Targeted NaA Nanozeolites for Prostate Cancer Therapy—Part II. Toxicity, Pharmacokinetics and … A Lankoff, M Czerwińska, R Walczak, U Karczmarczyk, K Tomczyk, ... International Journal of Molecular Sciences 22 (11), 5702, 2021 | 12 | 2021 |
| PSMA-D4 radioligand for targeted therapy of prostate cancer: synthesis, characteristics and preliminary assessment of biological properties P Garnuszek, U Karczmarczyk, M Maurin, A Sikora, J Zaborniak, ... International Journal of Molecular Sciences 22 (5), 2731, 2021 | 12 | 2021 |
| [99mTc]Tc-PSMA-T4—Novel SPECT Tracer for Metastatic PCa: From Bench to Clinic M Maurin, M Wyczółkowska, A Sawicka, AE Sikora, U Karczmarczyk, ... Molecules 27 (21), 7216, 2022 | 9 | 2022 |
| Synthesis and properties of targeted radioisotope carriers based on poly (acrylic acid) nanogels M Matusiak, BP Rurarz, S Kadłubowski, M Wolszczak, U Karczmarczyk, ... Pharmaceutics 13 (8), 1240, 2021 | 8 | 2021 |
| Does the number of bifunctional chelators conjugated to a mAb affect the biological activity of its radio-labeled counterpart? Discussion using the example of mAb against CD-20 … U Karczmarczyk, A Sawicka, P Garnuszek, M Maurin, W Wojdowska Journal of Medicinal Chemistry 65 (9), 6419-6430, 2022 | 7 | 2022 |
| PSMA targeted conjugates based on dextran M Janczewska, M Szkop, G Pikus, K Kopyra, A Świątkowska, K Brygoła, ... Applied Radiation and Isotopes 167, 109439, 2021 | 7 | 2021 |
| Comparison of chromatographic methods for quality control of DMSA complexes with 99mTc and 188Re at (III) and (V) oxidation states P Garnuszek, D Pawlak, M Maurin, D Jankovic, U Karczmarczyk, ... Nuclear Medicine Review 15 (2), 95-100, 2012 | 7 | 2012 |
| Nanostrategies for therapeutic and diagnostic targeting of gastrin-releasing peptide receptor BP Rurarz, M Bukowczyk, N Gibka, AW Piastowska-Ciesielska, ... International Journal of Molecular Sciences 24 (4), 3455, 2023 | 6 | 2023 |
| PSMA inhibitor derivatives for labelling with 99mTc via HYNIC, a radiopharmaceutical kit, radiopharmaceutical preparations and their use in prostate cancer diagnostics AE Sikora, M Maurin, AW Jaron, J Pijarowska-Kruszyna, M Wyczólkowska, ... US Patent 11,426,395, 2022 | 6 | 2022 |
| Clickable Radiocomplexes With Trivalent Radiometals for Cancer Theranostics: In vitro and in vivo Studies A D'Onofrio, F Silva, L Gano, U Karczmarczyk, R Mikołajczak, ... Frontiers in Medicine 8, 647379, 2021 | 6 | 2021 |
| Impact of DOTA-Chelators on the Antitumor Activity of 177Lu-DOTA-Rituximab Preparations in Lymphoma Tumor-Bearing Mice W Wojdowska, U Karczmarczyk, L Balog, A Sawicka, Z Pöstényi, ... Cancer Biotherapy & Radiopharmaceuticals 35 (8), 558-562, 2020 | 5 | 2020 |
| Influence of DOTA chelators on radiochemical purity and biodistribution of 177Lu-and 90Y-Rituximab in xenografted mice U Karczmarczyk, W Wojdowska, R Mikołajczak, M Maurin, E Laszuk, ... Iranian Journal of Pharmaceutical Research: IJPR 17 (4), 1201, 2018 | 5 | 2018 |
Piotr Garnuszek在 upcpoczta.pl 的电子邮件经过验证
